Discover the booming healthcare investment landscape as USD 115 billion flows into the sector, fueled by AI innovation, the ...

Priority voucher awardees and regulators could feel pressure to “meet the moment” as FDA watchers question the intent and ...

This prompted an unusual and bitter bidding war, where Doustdar goaded Pfizer to raise its bid during a press conference in the Oval Office. In the end, Pfizer won by matching Novo’s $10bn offer, as ...

Weight-loss drugs like Ozempic are difficult to access without cash, but is the answer to really to roll these out on the NHS ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

Trump deals with Eli Lilly and Novo Nordisk increase access to obesity drugs, providing a safe, convenient way to slim down ...

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

Eli Lilly is well on its way to the trillion-dollar club. The stock price is up 30% so far this year; with a total ...

A new study from the University of California San Diego has found that popular diabetes and weight-loss medications might ...

Viking Therapeutics shares have delivered explosive gains this week, climbing to their highest level in ten months. The ...

Pfizer eventually increased its offer. The company is now set to acquire Metsera in a deal worth up to $10 billion, including ...

European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from ...